Filing Details

Accession Number:
0001225208-13-013846
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-06-04 16:18:02
Reporting Period:
2013-05-31
Filing Date:
2013-06-04
Accepted Time:
2013-06-04 16:18:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
14272 Bristol Myers Squibb Co BMY Pharmaceutical Preparations (2834) 220790350
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1457948 J Beatrice Cazala Bristol-Myers Squibb Company
345 Park Avenue
New York NY 10154
Evp Commercial Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.10 Par Value Disposition 2013-05-31 91,282 $47.00 173,375 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, $0.10 Par Value 3,743 Indirect By BMY Savings & Investment Program
Footnotes
  1. Based on a plan statement as of the end of the most recent fiscal quarter.